The Creative Floor Awards winners announced
Area23 and McCann Health win big
Read More
Author: George Underwood
Health driving London’s digital lead in Europe
London leads this increasingly important study by a huge margin, finds new study
Read More
Gilead raises outlook despite dip in revenue
Total revenues were $5.6 billion in 2018 compared to $6.5 billion in 2017
Read More
Lundbeck schizophrenia drug fails Phase III trial
The drug was one of the company’s few original experimental drugs close to reaching the market
Read More
AbbVie assumes full development and commercial control of CF programme
Company announces revised agreement with Galapagos
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
